---
$id: https://graph.org.ai/products/commodity/51152006
$type: Product
source: UNSPSC
code: "51152006"
title: "Cisatracurium"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cisatracurium

**UNSPSC Code**: 51152006
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nicotinic antagonist with the molecular formula C53H72N2O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QX62KLI41N, chemically known as isoquinolinium, 2,2-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate, (1r-(1alpha,2alpha(1r(sup *),2r(sup *))))- but generally known as cisatracurium, which bears US NIH Compound Identifier 62886. European Medicines Agency schedules Cisatracurium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01319MIG. World Health Organization schedules cisatracurium in its Anatomical Therapeutic Chemical (ATC) Classification. CISATRACURIUM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, CISATRACURIUM remains the US FDA Preferred Term for this commodity. Cisatracurium bears US NLM identifiers UMLS ID C1096766 and NCI Concept Code C77365. SMILES: S(=O)(=O)(O)C1CCCCC1.S(=O)(=O)(O)C1CCCCC1.O(C1CC2C([N](CCC2CC1OC)(CCC(=O)OCCCCCOC(=O)CC[N]1(C(C2C(CC1)CC(OC)C(OC)C2)CC1CC(OC)C(OC)CC1)C)C)CC1CC(OC)C(OC)CC1)C.

